AI system shows high accuracy for diabetic retinopathy screening - Top-Institutions - MDSpire

AI system shows high accuracy for diabetic retinopathy screening

"AI could help reduce the burden on ophthalmology services by triaging large numbers of patients with diabetes and allowing specialists to focus on those who most urgently need care."

  • By

  • Olivia Anderson

  • March 20, 2026

  • 3 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts Institute of Technology (MIT) - Computer Science and Artificial Intelligence Laboratory (CSAIL)
    Massachusetts Institute of Technology (MIT) - Computer Science and Artificial Intelligence Laboratory (CSAIL)

    Cambridge, MA

    Key Differentiators

    • Artificial Intelligence
    • Ophthalmology
    • Medical Imaging

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Ophthalmology
    • Endocrinology
    • Artificial Intelligence

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Ophthalmology
    • Artificial Intelligence
    • Diabetes Research

  • #4

    Université Libre de Bruxelles (ULB) - Center for Diabetes Research
    Université Libre de Bruxelles (ULB) - Center for Diabetes Research

    Brussels, Brussels-Capital Region

    Key Differentiators

    • Diabetes Research
    • Ophthalmology
    • Artificial Intelligence

  • #5

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, CA

    Key Differentiators

    • Ophthalmology
    • Artificial Intelligence
    • Biomedical Informatics

Original Source(s)

AI system shows high accuracy for diabetic retinopathy screening

  • by Olivia Anderson

  • March 20, 2026

Related Content

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.

Machine Learning Prediction Model for Dyslipidemia and Its Association With Atherothrombotic Events in 3 Independent Cohorts From South Korea, Japan, and the United Kingdom: Algorithm Development and Validation Study

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.